MIMS Education
Courses for Doctors
GERD: Practice Essentials
This module aims to provide an overview of gastroesophageal reflux disease (GERD), discuss diagnostic options, and present treatment choices available for patients.
Cat 3B: 1 Point|
30 minutes|
01 Jul 2022
Plant Stanols and Dyslipidaemia: The Science Behind
Healthcare professionals are urged to recommend lifestyle modifications in addition to pharmacological intervention in managing patients with dyslipidaemia. The role of plant stanols in low-density lipoprotein cholesterol (LDL-C) lowering has been demonstrated in various studies across Western and Asian populations.
Cat 3A: 1 Point|
2h|
09 Apr 2022
Congenital Bleeding Disorders: How to Spot the Tell-Tale Signs
This module summarizes the essentials in the identification, multidisciplinary care, and preventive management of patients with congenital bleeding disorders (including hemophilia A and B).
Cat 3B: 1 Point|
30 minutes|
01 Jul 2022
OncoForum Melanoma Series: An Expert’s Highlights and Perspective on Malignant Melanoma
The course highlights the current trends in the treatment of melanoma, focusing on personalised medicine and the evidence base for combination treatment with BRAFi + MEK inhibitor in melanoma and existing clinical trials. The course also discusses adverse event management and introduces the clinical trials that examined adjuvant therapy with checkpoint inhibitors or targeted therapy in melanoma patients with high risk of recurrence.
Cat 3B: 1 Point|
2h|
01 Aug 2021
Direct-Acting Antivirals in the Treatment of Chronic Hepatitis C
This module aims to review the guidelines surrounding hepatitis C virus (HCV) infection and the direct-acting antivirals available for treatment.
Cat 3B: 1 Point|
30 minutes|
01 Jul 2022
SGLT2 inhibitors in heart failure management: Dissecting the path from diabetes to heart failure
This module summarizes the latest evidence of sodium-glucose co-transporter 2 inhibitors for the prevention of heart failure and cardiorenal outcomes.
Cat 3B: 1 Point|
30 minutes|
01 Jul 2022
Management Strategies for Irritable Bowel Syndrome
This module aims to equip the primary care doctor with the diagnostic and treatment framework to effectively manage mild to moderate
Cat 3B: 1 Point|
30 minutes|
01 Jul 2022
Stepping up in the fight against dengue
Dengue is the most rapidly spreading mosquito-borne viral disease in the world. This febrile illness is a leading cause of illness and death in the tropics and subtropics. Vector control in most endemic countries is frequently insufficient or ineffective due to inadequate infrastructure, delayed initiation, short-term interventions, and insecticide resistance. This course will discuss the prevention of dengue disease, including clinical evidence on the dengue vaccine.
Cat 3B: 1 Point|
2h|
08 Apr 2022
Never Too Old to Benefit from Lipid Lowering
This module aims to enhance the participant’s knowledge on the role of low-density lipoprotein cholesterol (LDL-C) management and the benefits of statins for primary prevention in the elderly.
Cat 3B: 1 Point|
30 minutes|
01 Jul 2022
Management Strategies for Chronic HBV Infection
The module focuses on prevention, screening, diagnosis, and guideline-based pharmacologic treatment of hepatitis B virus infection.
Cat 3B: 1 Point|
30 minutes|
01 Jul 2022
The Global Burden of Migraine: Overcoming Challenges with Innovation
As of 2016, migraine has a global prevalence of 14.1%, but the prevalence and severity of this disease is often underestimated. Furthermore, stigma still surrounds migraine at work and in society in general, as it is viewed as a ‘common problem’, hindering patients from receiving the proper treatment.
Cat 3A: 1 Point|
2h|
18 Aug 2021
An Approach to Fever and Rash in Children
The module aims to equip learners with tools for thorough clinical assessment, the establishment of differential diagnoses, and the development of management plans for children with fever and rash.
Cat 3B: 1 Point|
10 minutes|
01 Jul 2022
Empagliflozin’s Journey in the Cardio-Renal-Metabolic Continuum: What’s New?
In the EMPA-REG OUTCOME (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients) trial, empagliflozin demonstrated a reduction in cardiovascular events in patients with type 2 diabetes (T2D) and pre-existing cardiovascular disease. This online course covers the evidence base on the use of the sodium-glucose cotransporter 2 (SGLT2) inhibitor, empagliflozin, in the management of T2D patients with heart failure and chronic kidney disease.
1 Point|
2h|
13 Jul 2021
Diarrhoea: What To Look Out For
This module aims to familiarize the participant with the difference between acute and chronic diarrhoea in terms of aetiology, clinical manifestation, diagnosis, and management.
Cat 3B: 1 Point|
30 minutes|
01 Jul 2022
Understanding Dengue: Manifestation and Management
Dengue viruses can cause either symptomatic infections or asymptomatic seroconversion. Symptomatic infection is systemic and dynamic, with clinical, haematological and serological profiles that change from day to day. A knowledge of the changes during each phase of dengue disease will enable a rational approach in its management. This course will discuss the manifestations and management of dengue disease.
Cat 3B: 1 Point|
2h|
08 Apr 2022
Current management strategies for Helicobacter pylori infections
This module provides a holistic framework for screening, diagnosis, and initial treatment of H. pylori infection in the primary care setting.
Cat 3B: 1 Point|
30 minutes|
01 Jul 2022
Understanding Dengue: Epidemiology and Disease Burden
Dengue fever is a prevalent, potentially fatal but preventable infection. This mosquito-borne disease is a major cause of morbidity and mortality in Singapore. This course will discuss the epidemiology and burden of dengue disease.
Cat 3B: 1 Point|
2h|
08 Apr 2022
Learn on-demand
Online courses available on web and app
Accredited Courses
Recognised by local medical associations
Gain CPD/CME Points
Develop your clinical expertise
Courses for Pharmacists
The Allergic Rhinitis Bootcamp - Part 1 | Allergic Rhinitis Management and Patient Journey: Understanding the Disease and Current Guidelines
Allergic rhinitis (AR) is a common health complaint that affects patients of all ages. Untreated, AR can impair a person’s quality of life, sleep and social functioning. Nevertheless, most patients with AR are not treated according to guidelines and adherence to treatment is poor.
Cat 3A: 0.75 pts|
2h|
26 Oct 2021
The Allergic Rhinitis Bootcamp - Part 2 | Using patient profiles to guide antihistamine choice: An expert consensus
Allergic rhinitis (AR) is a common health complaint that affects patients of all ages. Untreated, AR can impair a person’s quality of life, sleep and social functioning. Nevertheless, most patients with AR are not treated according to guidelines and adherence to treatment is poor. The Allergic Rhinitis Boot Camp aims to provide pharmacists with a comprehensive review of the management of AR and practical recommendations for better patient outcomes.
Cat 3A: 0.75 pts|
2h|
02 Nov 2021